Journal Report

Current Drug Safety

Download PDF
Journal Information
Journal Title
Current Drug Safety
Publisher
Bentham Science Publishers
ISSN
1574-8863
E-ISSN
2212-3911
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Cefazolin-induced Supratherapeutic INR Coagulopathy Case Report
Thaddaus Hellwig, Jillian Songstad, Brooklynn A Downing et al.
2026-10-30 Vol. 22
Safety and Efficacy of Combination Antibiotics and Systemic Immunotherapy as Salvage Therapy for Severe Deep Neck Abscess: A Retrospective Case Series with Observational Analysis
Antonio Mastroianni, Roberto Manfredi, Antonio Siniscalchi et al.
2026-10-27 Vol. 22
A Retrospective Pharmacovigilance Study of Carmustine Using VigiBase: Safety Implications for Section 21 Access in South Africa
Mhlongo MP., Oosthuizen F., Mohammed MAG et al.
2026-10-26 Vol. 22
Disproportionality Analysis of Reporting Signals for Pericardial Disorders in the FDA Adverse Event Reporting System, 2000 to 2025
Kenneth L McCall, Kristin T Bush, Courtney E George et al.
2026-10-13 Vol. 21
Bilateral Lower Extremity Edema During Donepezil Treatment: A Case Report
Kyusik Kang
2026-10-8 Vol. 21
Efficacy and Safety of Sequential Combined Immunomodulatory Systemic Therapies Used in the Management of Refractory Cytokine Release Syndrome in Critically Ill Patients with COVID-19
Antonio Mastroianni, Luciana Chidichimo, Valeria Vangeli et al.
2026-9-29 Vol. 21
Duality of Rarity of Chemotherapy-induced Flagellate Erythema among Cancer Patients: A Case Report with 26 Years of Evidence in Oncology
Rajesh Krishna, Revathy Nandakumar, Rajesh Raju et al.
2026-9-25 Vol. 21
Pharmacovigilance Knowledge, Attitudes, and ADR Reporting Behaviour Among Physicians and Pharmacists in a Tertiary Hospital
Zühal Kaltuş, Ezgi Eroğlu, Sinem Gürcü et al.
2026-9-21 Vol. 21
Possible Interaction of the Gut-selective Antibiotic Rifaximin with Carvedilol Associated with Transient Indirect Hyperbilirubinemia: A Case Report
Dawesh Prakash Yadav, Aakanksha Jaiswal, Siddhartha Vats et al.
2026-9-9 Vol. 21
Safety of Chronic Proton Pump Inhibitor Therapy: An Updated Systematic Review of Serious Adverse Events
Harshitha Chowdary Chebrolu, Krishna Chaitanya Amerneni, Padmavathi R et al.
2026-8-22 Vol. 21
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 22:12